Home > Healthcare > Medical Devices > Implantable Devices > Coronary Artery Bypass Graft Market

Coronary Artery Bypass Graft Market Share

Report ID: GMI8564
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Coronary Artery Bypass Graft Market Share

The coronary artery bypass graft industry is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A key aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

Coronary Artery Bypass Graft Market Companies

Some of the eminent market participants operating in the coronary artery bypass graft industry include:

Abbott Laboratories
AngioDynamics
AtriCure
B. Braun Melsungen AG
Boston Scientific
Cardinal Health
CryoLife
Edwards Lifesciences
Johnson & Johnson
LivaNova
Medline Industries
Medtronic
Nipro Corporation
Stryker Corporation
Terumo Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for coronary artery bypass graft was reached USD 11.8 billion in 2023 and is estimated to grow at a 7.1% CAGR from 2024 to 2032, driven by the increasing prevalence of cardiovascular diseases.

The traditional (on-pump) CABG segment dominated the market with a 55.1% revenue share in 2023, due to its established efficacy and widespread adoption in surgical practices.

The grafts segment was valued at over USD 3.1 billion in 2023, as these are essential components in CABG procedures.

The U.S. coronary artery bypass graft market surpassed USD 3.5 billion in 2023 and is expected to grow at a 6.7% CAGR through 2032, led by favorable reimbursement policies and advanced healthcare infrastructure.

Key players in the industry include Abbott Laboratories, AngioDynamics, AtriCure, B. Braun Melsungen AG, Boston Scientific, Cardinal Health, CryoLife, Edwards Lifesciences, Johnson & Johnson, LivaNova, Medline Industries, Medtronic, Nipro Corporation, Stryker Corporation, and Terumo Corporation.